SIRION BIOTECH GmbH 16. Juli 2014

PROGRESS IN DRUG DISCOVERY [PDF]

SIRION BIOTECH specializes in viral vector platforms and provides sophisticated cell modeling. This enables much improved target identification and compound screening in the drug, the food & cosmetic industries. It also allows for much better chances to succeed with primary cell immortalizations. SIRION BIOTECH is able to construct adenovirus serotype vectors serving as the basis for novel future vaccines with much improved immunity.

SIRION Biotech wurde 2007 in München gegründet mit dem Ziel der Entwicklung neuartiger Zellmodelle sehr viel näher an der Realität als tr... [mehr]